Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles
Fisetin (FST), a potent anticancer phytoconstituent, exhibits poor aqueous solubility and hence poor bioavailability. The aim of the present study is to improve the oral bioavailability of FST by encapsulating into PLGA NPs (poly-lactide-co-glycolic acid nanoparticles) as a complex of HPβCD (hydroxy...
Main Authors: | Amrita Kadari, Sagarika Gudem, Hitesh Kulhari, Murali Mohan Bhandi, Roshan M. Borkar, Venkata Ramana Murthy Kolapalli, Ramakrishna Sistla |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2016.1245366 |
Similar Items
-
Fisetin: An Integrated Approach to Identify a Strategy Promoting Osteogenesis
by: Luca Dalle Carbonare, et al.
Published: (2022-05-01) -
Fisetin glycosides synthesized by cyclodextrin glycosyltransferase from Paenibacillus sp. RB01: characterization, molecular docking, and antioxidant activity
by: Nattawadee Lorthongpanich, et al.
Published: (2022-05-01) -
Fisetin—In Search of Better Bioavailability—From Macro to Nano Modifications: A Review
by: Joanna Szymczak, et al.
Published: (2023-09-01) -
Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics
by: Rachna M. Kumar, et al.
Published: (2023-01-01) -
Fisetin and polymeric micelles encapsulating fisetin exhibit potent cytotoxic effects towards ovarian cancer cells
by: Xue Xiao, et al.
Published: (2018-03-01)